Analyst David Buck is focused on the Healthcare sector with 50 price targets and ratings documented since 2015 spanning on 5 stocks. Previously, David Buck worked at B. RILEY, NORTHLAND CAPITAL MARKETS. Analyst's average stock valuation to be materialised ratio is 44.33% with an average time for price targets to be met of 206 days.
Most recent stock forecast was given on SUPN, Supernus Pharmaceuticals, Inc at 28-Jan-2019.
David Buck best performing recommendations are on MNK.
The best stock recommendation documented was for MNK at 12/31/2018. The price target of $21 was fulfilled within 25 days with a profit of $5.2 (32.91%) receiving and performance score of 13.16.
Average potential price target upside